Iterum Therapeutics (ITRM) Other Working Capital Changes (2017 - 2022)
Historic Other Working Capital Changes for Iterum Therapeutics (ITRM) over the last 6 years, with Q4 2022 value amounting to -$191000.0.
- Iterum Therapeutics' Other Working Capital Changes fell 13759.84% to -$191000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $1.6 million, marking a year-over-year increase of 3762.2%. This contributed to the annual value of $2.7 million for FY2024, which is 1646.8% down from last year.
- Latest data reveals that Iterum Therapeutics reported Other Working Capital Changes of -$191000.0 as of Q4 2022, which was down 13759.84% from $376000.0 recorded in Q3 2022.
- Iterum Therapeutics' 5-year Other Working Capital Changes high stood at $2.2 million for Q4 2018, and its period low was -$1.2 million during Q3 2019.
- Moreover, its 5-year median value for Other Working Capital Changes was $262644.0 (2021), whereas its average is $270361.8.
- In the last 5 years, Iterum Therapeutics' Other Working Capital Changes plummeted by 69426.75% in 2019 and then skyrocketed by 118911.36% in 2021.
- Over the past 5 years, Iterum Therapeutics' Other Working Capital Changes (Quarter) stood at $2.2 million in 2018, then crashed by 132.31% to -$713000.0 in 2019, then surged by 369.57% to $1.9 million in 2020, then tumbled by 73.57% to $508000.0 in 2021, then tumbled by 137.6% to -$191000.0 in 2022.
- Its Other Working Capital Changes was -$191000.0 in Q4 2022, compared to $376000.0 in Q3 2022 and $1.5 million in Q2 2022.